For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP51

2590

Dr.Sunayana N Murthy
Membership No Author Name Email Mobile
2590 Dr.Sunayana N Murthy sunayananm@gmail.com 9945042064
Cornea, Ocular Surface and External Eye Diseases

Determinants of Therapeutic Response to Losartan in Corneal Scarring : analysis & outcomes

To identify clinical and molecular determinants of response to topical losartan in corneal scarring through TGF-β and inflammatory biomarker profiling of responder versus non-responder phenotypes. In this study, 62 eyes with corneal scarring treated with losartan were followed for 12 months, classified as non-infectious or infectious/post-infectious. Tomography and OCT quantified scar depth/density, while cytology and tear profiling assessed fibrosis markers (TGF-β1, TGF-β2, collagen, α-SMA, fibronectin, lumican) and inflammatory markers (MMP-9, ICAM-1, IL-6, IL-8, IL-17A, TNF-α); TGF-β protein was measured by Western blot. Responders showed higher baseline TGF-β, a fibrosis-dominant, low-inflammatory profile, greater scar reduction (~22 µm), and better visual outcomes (p<0.05). Non-responders showed elevated MMP-9, TNF-α, IL-6, and IL-17A with limited improvement, and non-infectious scars predominated among responders; infectious scars showed an inflammation-driven, resistant profile

Membership No Author Name Email Mobile
865 Prof.Rohit Shetty drrohitshetty@yahoo.com 9611102568
Non Member Dr.swaminathan setu swaminathansethu@narayananethralayna.com 9840343313
Non Member Dr.Arkasubhra Ghosh 9591236580